This cohort study compares the sensitivity and specificity of a circulating tumor DNA assay with imaging, measurement of carcinoembryonic antigen (CEA) levels, and imaging plus CEA measurement for surveillance in patients with resected colorectal cancer as recommended by the National Comprehensive Cancer Network guidelines. The gene discussed is CEACAM5; the disease is neoplasm.